SIM0725
/ Simcere
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2025
Discovery and development of SIM0725, a long-acting anti-CD122 antagonistic antibody targeting pathogenic resident memory T cells for long-term vitiligo disease control
(EADV 2025)
- "SIM0725 demonstrated robust preclinical efficacy with on-target activity in both CHS and vitiligo models, supporting its further clinical development for vitiligo and other TRM-driven inflammatory disoders."
Contact Dermatitis • Dermatology • Immunology • Vitiligo • CD69 • CD8 • IL15 • IL2 • ITGAE
1 to 1
Of
1
Go to page
1